BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarrafzadegan N, Hassannejad R, Marateb HR, Talaei M, Sadeghi M, Roohafza HR, Masoudkabir F, Oveisgharan S, Mansourian M, Mohebian MR, Mañanas MA. PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region. PLoS One 2017;12:e0189389. [PMID: 29261727 DOI: 10.1371/journal.pone.0189389] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Mohebbian MR, Dinh A, Wahid K, Alam MS. Blind, Cuff-less, Calibration-Free and Continuous Blood Pressure Estimation using Optimized Inductive Group Method of Data Handling. Biomedical Signal Processing and Control 2020;57:101682. [DOI: 10.1016/j.bspc.2019.101682] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
2 Mansourian M, Khademi S, Marateb HR. A Comprehensive Review of Computer-Aided Diagnosis of Major Mental and Neurological Disorders and Suicide: A Biostatistical Perspective on Data Mining. Diagnostics (Basel) 2021;11:393. [PMID: 33669114 DOI: 10.3390/diagnostics11030393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fahimfar N, Malekzadeh R, Fotouhi A, Mansournia MA, Sarrafzadegan N, Azizi F, Sepanlou SG, Mansourian M, Hadaegh F, Emamian MH, Poustchi H, Talaei M, Pourshams A, Roohafza H, Sharafkhah M, Samavat T, Lotfaliany M, Steyerberg EW, Khalili D. An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country: Developing and validating an office-based model to predict cardiovascular mortality using cohorts of a middle-income country. J Clin Epidemiol 2021:S0895-4356(21)00420-0. [PMID: 34920114 DOI: 10.1016/j.jclinepi.2021.12.017] [Reference Citation Analysis]
4 Ashraf H, Karbalai S, Jamali R. Nonalcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration. WJMA 2021;9:163-74. [DOI: 10.13105/wjma.v9.i2.163] [Reference Citation Analysis]
5 Amiri ZS, Khajedaluee M, Rezaii A, Dadgarmoghaddam M. The risk of cardiovascular events based on the Framingham criteria in Adults Living in Mashhad (Iran). Electron Physician 2018;10:7164-73. [PMID: 30214698 DOI: 10.19082/7164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Roohafza H, Noohi F, Hosseini SG, Alemzadeh-ansari M, Bagherieh S, Marateb H, Mansourian M, Mousavi AF, Seyedhosseini M, Farshidi H, Ahmadi N, Yazdani A, Sadeghi M. A Cardiovascular Risk Assessment model according to behavioral, pSychosocial and traditional factors in patients with ST-segment elevation Myocardial Infarction (CRAS-MI): review of literature and methodology of a multi-center cohort study. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101158] [Reference Citation Analysis]
7 Hassannejad R, Mansourian M, Marateb H, Mohebian MR, Gaziano TA, Jackson RT, Angelantonio ED, Sarrafzadegan N. Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models. Glob Heart 2021;16:58. [PMID: 34692382 DOI: 10.5334/gh.890] [Reference Citation Analysis]
8 Sarrafzadegan N, Hassannejad R, Marateb HR, Talaei M, Sadeghi M, Roohafza HR, Masoudkabir F, Oveisgharan S, Mansourian M, Mohebian MR, Mañanas MA. Correction: PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region. PLoS One 2018;13:e0191379. [PMID: 29370204 DOI: 10.1371/journal.pone.0191379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Marateb HR, Mohebian MR, Javanmard SH, Tavallaei AA, Tajadini MH, Heidari-Beni M, Mañanas MA, Motlagh ME, Heshmat R, Mansourian M, Kelishadi R. Prediction of dyslipidemia using gene mutations, family history of diseases and anthropometric indicators in children and adolescents: The CASPIAN-III study. Comput Struct Biotechnol J 2018;16:121-30. [PMID: 30026888 DOI: 10.1016/j.csbj.2018.02.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Perry BI, Upthegrove R, Crawford O, Jang S, Lau E, McGill I, Carver E, Jones PB, Khandaker GM. Cardiometabolic risk prediction algorithms for young people with psychosis: a systematic review and exploratory analysis. Acta Psychiatr Scand 2020;142:215-32. [PMID: 32654119 DOI: 10.1111/acps.13212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Marateb HR, von Cube M, Sami R, Haghjooy Javanmard S, Mansourian M, Amra B, Soltaninejad F, Mortazavi M, Adibi P, Khademi N, Sadat Hosseini N, Toghyani A, Hassannejad R, Mañanas MA, Binder H, Wolkewitz M. Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study. BMC Med Res Methodol 2021;21:146. [PMID: 34261439 DOI: 10.1186/s12874-021-01340-8] [Reference Citation Analysis]
12 Sarrafzadegan N, Hassannejad R, Roohafza H, Sadeghi M, Talaei M, Oveisgharan S, Mansourian M. A 10-year Isfahan cohort on cardiovascular disease as a master plan for a multi-generation non-communicable disease longitudinal study: methodology and challenges. J Hum Hypertens 2019;33:807-16. [PMID: 30385824 DOI: 10.1038/s41371-018-0126-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Ashraf H, Karbalai S, Jamali R. Nonalcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration. World J Meta-Anal 2021; 9(2): 164-175 [DOI: 10.13105/wjma.v9.i2.164] [Reference Citation Analysis]
14 Sheikh A, Nurmatov U, Al-Katheeri HA, Ali Al Huneiti R. Risk prediction models for atherosclerotic cardiovascular disease: A systematic assessment with particular reference to Qatar. Qatar Med J 2021;2021:42. [PMID: 34604019 DOI: 10.5339/qmj.2021.42] [Reference Citation Analysis]